person

Theodora P.

Country
Greece
Department
Clinical Therapeutics

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
24
Sites with multiple studies

Has run more than one trial at 24 of 218 partner sites.

Specializations

Urologic Oncology

The investigator specializes in treating muscle-invasive bladder cancer (MIBC), focusing on innovative therapeutic approaches for bladder preservation. Their research interests encompass urothelial carcinoma management and advanced treatment modalities.

  • Bladder Cancer Therapeutics
  • Organ Preservation Strategies
  • Urologic Malignancies

Primary focus includes exploring combination therapies and novel treatment approaches for bladder cancer patients.

Immunotherapy Research

The investigator explores immunotherapeutic interventions in urologic cancers, with particular attention to novel drug delivery systems and immune checkpoint inhibitors. Their work involves evaluating emerging therapeutic combinations for bladder cancer treatment.

  • Novel Drug Delivery Systems
  • Combination Immunotherapy
  • Targeted Cancer Treatments

Areas of investigation include local drug delivery mechanisms and immunotherapy combinations in urologic oncology.

Multimodal Cancer Care

The investigator studies chemoradiotherapy approaches in bladder cancer treatment, comparing traditional and innovative therapeutic strategies. Their research explores alternative treatment options to standard concurrent therapy protocols.

  • Combined Modality Treatment
  • Treatment Optimization
  • Clinical Outcomes Assessment

Expertise includes evaluating survival outcomes and quality of life metrics in bladder cancer patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.